Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$1.14
CAD
-0.46 (-28.75%)
Last updated: 2026-10-27
Follow CRDL
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
+1.25%
1 Week
-0.61%
1 Month
-33.33%
YTD
+19.12%
Key Statistics
Market Cap
$196.85M
52W High
$3.23
52W Low
$1.23
P/E Ratio
-
50 Day MA
$2.36
200 Day MA
$1.81
Beta
0.72
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/27/2026 | $1.59 | $1.63 | $1.59 | $1.62 | $1.62 | 81,606 |
| 10/26/2026 | $1.60 | $1.61 | $1.57 | $1.60 | $1.60 | 63,535 |
| 10/23/2026 | $1.65 | $1.65 | $1.55 | $1.59 | $1.59 | 134,973 |
| 10/22/2026 | $1.66 | $1.67 | $1.61 | $1.64 | $1.64 | 133,566 |
| 10/21/2026 | $1.63 | $1.66 | $1.62 | $1.66 | $1.66 | 143,282 |
| 10/20/2026 | $1.57 | $1.64 | $1.54 | $1.63 | $1.63 | 134,567 |
| 10/19/2026 | $1.57 | $1.58 | $1.53 | $1.57 | $1.57 | 97,738 |
| 10/16/2026 | $1.62 | $1.62 | $1.54 | $1.58 | $1.58 | 143,940 |
| 10/15/2026 | $1.64 | $1.65 | $1.60 | $1.60 | $1.60 | 279,375 |
| 10/14/2026 | $1.70 | $1.70 | $1.60 | $1.60 | $1.60 | 158,320 |
Analyst Price Targets
Based on analyst covering CRDL · as of Oct 12, 2026
Wall Street analysts forecast CRDL stock price to rise 514.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.00
+514.0% Upside
Previously C$6.00 on Sep 17, 2026
Current Price
C$1.14
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
50.2%
Annualized
90-Day Vol
66.1%
Annualized
Trend (90d)
-22.7%
Annualized drift
90d Mean
C$1.49
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.58 | C$1.33 – C$1.88 |
| 60 trading days | C$1.53 | C$1.20 – C$1.96 |
| 90 trading days | C$1.49 | C$1.11 – C$2.02 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.34
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SLT | Saltire Capital Ltd. | $2.50 | +25.00% |
| BNG | Bengal Energy Ltd | $0.03 | +20.00% |
| ARN | Asarian Energy Limited | $0.43 | +17.81% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.04 | +16.67% |
| XNDU | Xanadu Quantum Technologies Limited | $4.13 | +15.36% |
| SLR | Solitario Exploration & Royalty Corp | $0.74 | +12.12% |
| CLS | Celestica Inc. | $388.33 | +11.92% |
| LAM | Laramide Resources Ltd. | $0.48 | +11.63% |
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestTop penny stocks on the TSX & TSXV — October 15, 2026
October 2026
- Why Cardiol Therapeutics Inc Class A stock fell yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock fell yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?
- Why Cardiol Therapeutics Inc Class A stock is tanking today
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
September 2026
- What's Going On With Cardiol Therapeutics Inc Class A Stock Wednesday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Friday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Monday?
- Why Cardiol Therapeutics Inc Class A stock surged yesterday